NewsRack: 'india' news in 'IP' topic for user prashantiyengar

SPECIAL: Ranbaxy's dark chapter (Cached)	24.5.2013	Rediff: Business
The company has admitted it fudged data so that it could launch its products in the United States. It has now paid $500 million as a penalty to settle the case.
Also found in: [+]
US urged to take tougher line on Indian trade practices (Cached)	15.5.2013	TOI: Intl Business
"The United States should not sit idly by as the Indian government enacts regulations that harm American industry and jobs," Stephen Ezell, senior analyst at the Information Technology & Innovation Foundation (ITIF), said in a paper.
Also found in: [+]
Top Indian generic drug makers look to US as patents end (Cached)	9.5.2013	Rediff: Business
They seek to profit from big-selling drugs going off-patent this year in the lucrative market.
Also found in: [+]
Speech by the President of India, Shri Pranab Mukherjee on the occasion of the Convocation 2013 of Sido Kanhu Murmu (Cached)	30.4.2013	Govt of india: PIB
Speech by the President of India, Shri Pranab Mukherjee on the occasion of the Convocation 2013 of Sido Kanhu Murmu
Also found in: [+]
License for Manufacturing Generic Anti-Cancer Drugs (Cached)	30.4.2013	Govt of india: PIB
License for Manufacturing Generic Anti-Cancer Drugs
Also found in: [+]
Little support for pharma MNCs on patent issue (Cached)	27.4.2013	TOI: Intl Business
Multinational drug companies that are complaining against the Indian government and patent authorities using flexibilities under the World Trade Organisation’s Agreement on Trade Related Aspects of Intellectual Property rights are finding little support in the international community.
Also found in: [+]
Growth will be back on track by elections, says FM (Cached)	18.4.2013	Rediff: Business
US Chamber of Commerce attacks India over intellectual property rights.
Also found in: [+]
Made-in-India generics have low prices, meet high quality standards (Cached)	16.4.2013	TOI: India
Made-in-India generics have low prices, meet high quality standards
Also found in: [+]
COLUMN: Struggle for life saving drugs (Cached)	16.4.2013	Rediff: Business
People die from diseases like AIDS, TB, etc because life saving essential medicines are either too expensive, or not available because they are not seen as financially viable.
Also found in: [+]
Struggle for life saving drugs (Cached)	16.4.2013	Rediff: Columns
People die from diseases like AIDS, TB, etc because life saving essential medicines are either too expensive, or not available because they are not seen as financially viable.
Also found in: [+]
Pfizer reduces field staff base in India (Cached)	16.4.2013	Rediff: Business
Employees allege forcible layoffs; firm says ensuring it "best maximises performance and optimises resources"
Also found in: [+]
Novartis has 219 patents in India (Cached)	15.4.2013	Rediff: Business
Data contradict Swiss drug major's claim that India does not respect IPR.
Also found in: [+]
India refutes US criticism of its FDI, IPR laws (Cached)	13.4.2013	Rediff: Business
USTR has said India imposed several barriers in major services industries such as insurance, banking, audiovisual, accounting, legal, telecommunications, distribution services, postal and express delivery services.
Also found in: [+]
'India, EU showing political will to seal FTA' (Cached)	12.4.2013	Rediff: Business
India was apprehensive because EU was pushing for data exclusivity provisions that would have affected domestic pharma companies.
Also found in: [+]
Should pharma MNCs be peeved? (Cached)	12.4.2013	Rediff: Business
In spite of all their complaints, pharma MNCs have been gaining market share in India. And this growth has come largely with generics.
Also found in: [+]
Should pharma MNCs be peeved? (Cached)	12.4.2013	Rediff: Columns
In spite of all their complaints, pharma MNCs have been gaining market share in India. And this growth has come largely with generics.
Also found in: [+]
Indian patent rulings may face legal heat internationally (Cached)	11.4.2013	ET: Policy
Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India
Also found in: [+]
Novartis case:Supreme Court ruling wise and balanced (Cached)	10.4.2013	Rediff: Interviews
Supreme Court is saying that consumers should not be forced to pay higher prices just because it is chemically a new drug unless there is a therapeutic benefit involved.
Also found in: [+]
'Novartis ruling: It is not an anti-patent judgement' (Cached)	10.4.2013	Rediff: Business
Supreme Court is saying that consumers should not be forced to pay higher prices just because it is chemically a new drug unless there is a therapeutic benefit involved.
Also found in: [+]
Column: What was the Novartis case really about? (Cached)	8.4.2013	Rediff: Business
The drug Glivec was a genuinely new and important discovery deserving of patent protection.
Also found in: [+]

1 to 20 of 2,157